GOLDMAN SACHS GROUP INC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 51 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$72,013
-66.7%
49,324
-47.7%
0.00%
Q2 2023$215,972
+1442.7%
94,311
+446.4%
0.00%
Q3 2022$14,000
-64.1%
17,261
-56.7%
0.00%
Q2 2022$39,000
-66.4%
39,850
-43.6%
0.00%
Q1 2022$116,000
-54.5%
70,595
-33.3%
0.00%
Q4 2021$255,000
+110.7%
105,805
+323.9%
0.00%
Q3 2021$121,000
+77.9%
24,958
-2.4%
0.00%
Q2 2021$68,000
-28.4%
25,583
-16.9%
0.00%
Q1 2021$95,000
-67.4%
30,804
-62.3%
0.00%
Q4 2020$291,000
-29.9%
81,754
-21.1%
0.00%
Q3 2020$415,000
+33.4%
103,558
-9.4%
0.00%
Q2 2020$311,000
+31.8%
114,280
+2.0%
0.00%
Q1 2020$236,000
-59.5%
112,065
+4.6%
0.00%
Q4 2019$583,000
+223.9%
107,176
+79.0%
0.00%
Q3 2019$180,000
-21.1%
59,883
-1.6%
0.00%
Q2 2019$228,000
+109.2%
60,832
+124.4%
0.00%
Q1 2019$109,000
-24.3%
27,103
-31.1%
0.00%
Q4 2018$144,000
-57.0%
39,357
+0.9%
0.00%
Q3 2018$335,000
-60.9%
39,013
-50.0%
0.00%
Q2 2018$856,000
+110.8%
77,975
+121.5%
0.00%
Q1 2018$406,000
+60.5%
35,205
+44.3%
0.00%
Q4 2017$253,000
+46.2%
24,395
+101.4%
0.00%
Q4 2016$173,000
-57.4%
12,110
-51.0%
0.00%
Q3 2016$406,000
+158.6%
24,690
+124.3%
0.00%
Q2 2016$157,000
-59.3%
11,010
-58.7%
0.00%
Q1 2016$386,00026,6430.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders